BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Advantages of Umbilical Cord Blood for Use in HSCT
Technical Advantages of Cord Blood

Advantages of Umbilical Cord Blood for Use in HSCT

February 20, 2015 By Cade Hildreth (CEO) Leave a Comment

The stem cells found in cord blood are largely hematopoietic stem cells, which can help in the replenishment of a depleted blood supply by providing new, healthy cells. In the case of certain diseases, such as leukemia, anemia, lymphoma, and others where the blood cells and tissues are severely affected, this replenishment is essential.

Discover class-defining bioproduction tools.

There are several important properties of cord blood, including that the number of hematopoietic stem cells in cord blood equals, or exceeds, the frequency of hematopoietic stem cells in bone marrow. In addition, cord blood hematopoietic stem cells can produce large colonies in vitro, have different growth factor requirements, and can be expanded in long-term culture.[1]

Also, cord blood stem cells are characterized as multipotent, because they are capable of differentiating into numerous stem cell types, including neurons, hepatic cells, and circulating cell types.[2]

Technical Advantages of Umbilical Cord Blood Stem Cells

Umbilical cord blood stem cells are often induced into cells found within the blood and lymph (immune) systems, such as red blood cells, white blood cells, and platelets. The ability of cord blood stem cells to differentiate into blood and immune system cells means they hold significant potential for use in treatment cancer, blood disorders, immunodeficiencies, and more.

Rooster DevServices

Cord blood stem cells are used in similar ways to stem cells from bone marrow, meaning that transplantation is typically used to promote re-building of a patient’s blood and immune system.

It is now clear that cord blood is a validated, effective treatment approach for a number of blood related diseases, as well as an effective source of blood forming stem cells.  The image shown below shows the technical advantages of cord blood transplant, over bone marrow or peripheral blood stem cell transplant:

bitbio

Technical Advantages of Cord Blood, Over Bone Marrow or Peripheral Blood Stem Cell TransplantNote: Click to enlarge.

Because umbilical cord blood is a source of stem cells that are genetically unique to a newborn and potentially compatible for those who are closely related, parents may elect to preserve these cells as a form of “medical insurance.” As mentioned, umbilical cord blood stem cell transplants are less prone to rejection than either bone marrow or peripheral blood stem cell transplants because the cells are collected before they develop features that can be recognized and attacked by a recipient’s immune system.

Pluristyx

As such, there is a reduced chance that transplanted cord blood stem cells will attack the recipient’s body (Graft-versus-host disease).

Both the versatility and availability of umbilical cord blood stem cells make them a potent resource for use in transplant medicine. Due in part to this, the use of cord blood has increased substantially since its discovery as a form of cellular therapy.

iPSC-derived cardiomyocte therapy

To learn more, view the “Complete 2017-18 Global Cord Blood Banking Industry Report.”

About BioInformant

As the first and only market research firm to specialize in the stem cell industry, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.

Footnotes
[1] Rogers I, Casper RF (2004). Umbilical cord blood stem cells. Best Practice & Research Clinical Obstetrics & Gynaecology.
[2] Ilancheran, et al. (2009). Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta. 2009;1:2-10.

Rate this post

Filed Under: Cord Blood, HSCs Tagged With: cord blood, cord blood transplant, hematopoietic stem cells, technical advantages

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Featured Posts

what are exosomes | definition

What are Exosomes, Exactly?

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.